苏轩堂上涨3.68%，报1.41美元/股，总市值1.64亿美元

Group 1 - The core viewpoint of the article highlights the performance of Su Xuan Tang (SXTC) stock, which opened at $1.41 per share, reflecting a 3.68% increase, with a total market capitalization of $164 million as of December 15 [1] - Financial data indicates that as of March 31, 2025, Su Xuan Tang reported total revenue of $1.7409 million, representing a year-on-year decrease of 9.73%, and a net profit attributable to shareholders of -$3.3037 million, down 6.62% year-on-year [1] - Su Xuan Tang Pharmaceutical Co., Ltd. is identified as an innovative Chinese pharmaceutical company focusing on the research, production, and sales of traditional Chinese medicine pieces, particularly modern oral and infusion forms [1]